Unlock instant, AI-driven research and patent intelligence for your innovation.
Dipeptide DL with double functions of lowering blood pressure and lowering blood fat and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A lipid-lowering, dual-function technology applied in the field of active dipeptides
Active Publication Date: 2015-03-25
ZHEJIANG ACADEMY OF AGRICULTURE SCIENCES
View PDF3 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0019] According to existing drug reports, except for traditional Chinese medicines, drugs that have both blood pressure and blood fat lowering effects are rare
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0057] 1) ACE inhibitory activity of dipeptide DL at a concentration of 1.0 mg / mL:
[0058] Chromatographic conditions: Solvent I is 0.05% trifluoroacetic acid (TFA) and 0.05% triethylamine (TTA) dissolved in deionized water (that is, every liter of solvent I contains 0.5mL of trifluoroacetic acid and 0.5mL of triethylamine ), solvent II is 100% chromatographically pure acetonitrile. The ratio of solvent Ⅰ to solvent Ⅱ is 70%: 30% (volume ratio), ultimate3000 Diane liquid chromatograph, and the chromatographic column is watersSymmetry C 18 5μm4.6×250mm, the flow rate is 0.5mL / min, the injection volume is 10μL, the detection wavelength is 225nm, and the detection column temperature is 30°C.
[0059] Detection method: The dipeptide DL obtained by chemical synthesis is tested for activity (the detection method is the same as above). At this time, the DL concentration was 1.0 mg / mL.
[0060] Results: The ACE inhibitory activity of dipeptide DL at 1.0 mg / mL was 81.28%.
[0061]...
Embodiment 2
[0066] 1) ACE inhibitory activity of dipeptide DL at a concentration of 2.0 mg / mL:
[0067] Chromatographic conditions: solvent Ⅰ is 0.05% trifluoroacetic acid (TFA) and 0.05% triethylamine (TTA) dissolved in deionized water; solvent Ⅱ is 100% chromatographically pure acetonitrile. The ratio of solvent Ⅰ to solvent Ⅱ is 70%: 30%, the ultimate3000 Diane liquid chromatograph, the chromatographic column is waters Symmetry C 18 5μm4.6×250mm, the flow rate is 0.5mL / min, the injection volume is 10μL, the detection wavelength is 225nm, and the detection column temperature is 30°C.
[0068] Detection method: The dipeptide DL obtained by chemical synthesis is tested for activity (the detection method is the same as above). At this time, the DL concentration was 2.0 mg / mL.
[0069] Results: The ACE inhibitory activity of dipeptide DL at 2.0 mg / mL was 87.81%.
[0070] 2) HMG-CoA reductase inhibitory activity of dipeptide DL at a concentration of 2.0 mg / mL:
[0071] Chromatographic co...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention belongs to the technical field of biology, and particularly relates to a dipeptide capable of being combined with angiotensin converting enzyme to inhibit activity of the angiotensin converting enzyme and inhibit activity of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase. The invention particularly discloses a dipeptide DL with double functions of lowering blood pressure and lowering blood fat, wherein the amino acid sequence of the dipeptide DL is Asp Leu. The invention also discloses application of the dipeptide DL in preparing ACE (angiotensin converting enzyme) inhibitory peptide and / or HMG-CoA reductase inhibitory peptide.
Description
technical field [0001] The invention belongs to the field of biotechnology, and particularly relates to an angiotensin-converting enzyme that can be combined to inhibit its activity, and can also inhibit the activity of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase of dipeptides. Background technique [0002] Angiotensin converting enzyme (Angiotensin converting enzyme, ACE, EC3.4.15.1, once used in the literature as kininaseIl, dipeptidyl carboxypeptidase I, etc.) is a dicarboxypeptidase, which is a key enzyme leading to high blood pressure. It passes Hydrolysis converts angiotensin I to angiotensin II, and at the same time, ACE can also inactivate bradykinin, both of which can lead to vasoconstriction and thus hypertension. Therefore, ACE is considered to be an important factor causing hypertension. Studies have found that angiotensin-converting enzyme inhibitors (ACEI) can lower blood pressure by inhibiting the activity of ACE. ACE inhibitors are widely use...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.